What are the recommended workup and treatment for Hashimoto encephalopathy?

Hashimoto's Encephalitis: Workup and Treatment Recommendations

For suspected Hashimoto's encephalitis (also called steroid-responsive encephalopathy associated with autoimmune thyroiditis, or SREAT), immediately obtain anti-thyroid peroxidase (TPO) and anti-thyroglobulin antibodies, perform comprehensive neurologic workup to exclude other causes, and initiate high-dose corticosteroids (methylprednisolone 1 g IV daily for 3-5 days) once infectious and other autoimmune causes are ruled out.

Diagnostic Workup

Essential Laboratory Studies

• Serum anti-thyroid antibodies: Anti-TPO and anti-thyroglobulin antibodies are the diagnostic cornerstone 123
• Thyroid function tests: TSH and free T4 (note: many patients are euthyroid; thyroid function does NOT correlate with disease severity) 13
• Autoimmune encephalitis panel: Including NMDAR, LGI1, CASPR2, AMPAR, GABA-B receptor antibodies to exclude other autoimmune encephalitides 14
• Paraneoplastic antibody panel: Especially in patients with cancer risk factors (smokers, elderly, weight loss) 14
• Basic metabolic panel, CBC, ESR, CRP 1
• AM cortisol and ACTH to rule out adrenal insufficiency 1

Neuroimaging

• MRI brain with and without contrast: May show T2/FLAIR changes typical of autoimmune encephalopathy or may be completely normal (36% show abnormalities) 145
• Look for bilateral limbic involvement, cortical/subcortical changes, or other patterns consistent with autoimmune encephalitis 4

Lumbar Puncture

Perform CSF analysis including 1:

• Opening pressure
• Cell count and differential (may show lymphocytic pleocytosis)
• Protein (commonly elevated) and glucose
• Gram stain, bacterial and viral cultures
• PCR for HSV and other viruses depending on clinical suspicion
• Cytology to exclude malignancy
• Oligoclonal bands
• Autoimmune encephalopathy and paraneoplastic panels

Additional Studies

• EEG: Abnormalities present in 80% of cases, useful to evaluate for subclinical seizures 15
• Neurology consultation: Mandatory for all suspected cases 1

Treatment Algorithm

Initial Management (While Awaiting Results)

1. Start empiric IV acyclovir until viral PCR results return negative 16
2. Consider antibacterial coverage until bacterial infection excluded 1
3. Neurology consultation immediately 1

Definitive Treatment Once Diagnosis Confirmed

First-Line: High-Dose Corticosteroids

• Methylprednisolone 1 g IV daily for 3-5 days, followed by oral prednisone taper over 4-6 weeks minimum 16278
• Alternative dosing: Methylprednisolone 1-2 mg/kg/day if less severe presentation 16

Second-Line Therapies (for severe/refractory cases) If symptoms are severe, progressing, or oligoclonal bands are present 16:

• IVIG: 2 g/kg over 5 days (0.4 g/kg/day) 16
• Plasmapheresis: 5 sessions 16
• Rituximab: Consider if positive for specific autoimmune antibodies and limited improvement 16

Thyroid Management

• Levothyroxine replacement if hypothyroid (dose based on TSH, typically 1.6 mcg/kg/day for younger patients without cardiac disease) 19
• Treat any thyroid dysfunction, though this alone does not resolve the encephalopathy 2

Steroid Taper

• Taper oral prednisone over at least 4-6 weeks after acute management 1
• Monitor closely for symptom recurrence during taper 1
• Some sources suggest up to 13 weeks for complete taper 7

Critical Pitfalls to Avoid

1. Do not assume normal thyroid function excludes the diagnosis: Many patients with Hashimoto's encephalitis are euthyroid 3
2. Antibody titers do not correlate with severity: High or low titers both can cause severe disease 3
3. Must exclude other autoimmune encephalitides: Anti-thyroid antibodies can be present in normal individuals and other autoimmune diseases; always test for neuronal surface antibodies 42
4. Do not delay treatment waiting for antibody results: If clinical suspicion is high and infectious causes excluded, start corticosteroids empirically 1
5. Consider IgG4-related disease variant: Younger males with very high thyroid antibody titers and more aggressive presentation may have IgG4-related Hashimoto's thyroiditis 2

Special Considerations

Clinical Phenotypes to Recognize 5:

• Acute encephalopathy (most common, 58%)
• Chronic psychiatric form (17%)
• Cerebellar ataxic form (16%)
• CJD-like presentation
• Limbic encephalitis pattern

Common Presenting Features 5:

• Altered mental status/confusion (66%)
• Psychosis/hallucinations (53%)
• Dementia/cognitive decline (38%)
• Seizures (31%)
• Involuntary movements—tremor or myoclonus (31%)
• Ataxia (28%)

Prognosis: Generally favorable with aggressive corticosteroid treatment; most cases are monophasic and steroid-responsive 2310. However, some cases may not respond to steroids alone and require additional immunosuppression 2.